Insider: O'Kane Kieran Chief Commercial Officer - BIODESIX INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 140,065 | 0 | 140,065 |
| Value | $1,085,503.75 | $0.00 | $1,085,503.75 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/13/2025 | DDS | 476 | Direct | COM | $0.42 | $198.16 | 140,065 |
| 05/13/2025 | DDS | 238 | Direct | COM | $0.35 | $83.99 | 139,052 |
| 05/12/2025 | DDS | 239 | Direct | COM | $0.36 | $85.90 | 139,290 |
| 02/11/2025 | DDS | 17,527 | Direct | COM | $0.92 | $16,198.45 | 128,039 |
| 11/12/2024 | DDS | 224 | Direct | COM | $1.40 | $313.78 | 97,448 |
| 11/11/2024 | DDS | 238 | Direct | COM | $1.39 | $331.03 | 97,672 |
| 08/12/2024 | DDS | 120 | Direct | COM | $1.57 | $188.63 | 89,628 |
| 08/09/2024 | DDS | 345 | Direct | COM | $1.60 | $552.35 | 89,748 |
| 05/09/2024 | DDS | 468 | Direct | COM | $1.48 | $692.41 | 75,524 |
| 02/12/2024 | DDS | 5,412 | Direct | COM | $1.66 | $9,009.36 | 68,005 |
| 02/09/2024 | DDS | 6,319 | Direct | COM | $1.92 | $12,111.00 | 73,417 |
| 11/10/2023 | DDS | 235 | Direct | COM | $1.23 | $288.02 | 47,712 |
| 11/09/2023 | DDS | 234 | Direct | COM | $1.27 | $297.34 | 47,947 |
| 08/10/2023 | DDS | 849 | Direct | COM | $1.27 | $1,075.60 | 46,692 |
| 08/09/2023 | DDS | 850 | Direct | COM | $1.39 | $1,180.06 | 47,541 |
| 05/10/2023 | DDS | 474 | Direct | COM | $1.58 | $747.07 | 36,757 |
| 05/09/2023 | DDS | 1,223 | Direct | COM | $1.57 | $1,915.71 | 37,231 |
| 02/09/2023 | DDS | 1,999 | Direct | COM | $1.80 | $3,596.40 | 22,993 |
| 11/10/2022 | DDS | 753 | Direct | COM | $1.02 | $766.18 | 15,184 |
| 11/09/2022 | DDS | 952 | Direct | COM | $1.04 | $991.79 | 15,937 |
| 08/09/2022 | DDS | 1,673 | Direct | COM | $2.53 | $4,229.68 | 11,428 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research